SEC Tracker
Get the app

Oculis Holding OCS

Oculis Holding raises $110M through share offerings

Foreign issuer report

Form
6-K
Filed
Importance
Routine
  1. Raised $110M before expenses from offering 5,432,098 shares at $20.25 each
  2. Underwriters have 30-day option to buy 703,703 additional shares at $20.25
  3. Offerings expected to close on November 3, 2025
  4. Net proceeds will fund operations until late 2028

Written from the 6-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Oculis Holding files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX